NAZMED SMS SDN BHD
Malaysia
Manufacturer/ Producer
NAZMED SMS (Surgical Medical Supplies) honorably introduce itself as a competent manufacturer and exporter of all sorts of quality Surgical & Dental instruments, a comprehensive range of Scissors along with the Orthopedic line. SMS (Surgical Medical Supplies) do believe in-time supply of reliable products with innovative features for Customer satisfaction. SMS comprehensive technical experience, progressive penetration in the indigenous International markets and guaranteed best qualities are acknowledged and acclaimed throughout the world. All of SMS (Surgical Medical Supplies) products are made under strict quality control regulations and by skilled labor. Quality control is rigorously enforced at every stage of manufacturing, final inspection and even on standard of packing. Being a CGMP certified as well, the Management strictly follows the policy of not employing child labor in keeping with moral and international laws.
Website
Manufacturer/ Producer
No. 12-3, Jalan USJ 21/4, Subang Jaya, 47630 Subang Jaya, Selangor, Malaysia.
47630 Subang Jaya, Selangor - Malaysia
Company info
Key figures
-
- Company headcount
- 51 – 100
Organisation
-
- Year established
- 1992
-
- pages.epage-home.site-status
- Registered office
-
- Main activity
- Manufacturer/ Producer
Activities of NAZMED SMS SDN BHD
- Medical and surgical instruments
- surgical instruments
- Dental Instruments
europages also recommends
A selection of companies related to the activity:
A selection of products that might interest you
MPS MICRO PRECISION SYSTEMS AG
Switzerland
Novostia, a Swiss startup founded in 2017, has entrusted MPS with the manufacture of its TRIFLO artificial valve, a revolutionary aortic prosthesis on several levels. Thanks to its aerodynamic design, the presence of three leaflets and the absence of physical pivot axes for the leaflets, the TRIFLO valve aims to satisfy the following three criteria: - A device lifespan at least equal to that of the patient, to avoid the need for a second surgical procedure. This means more than 30 million flap openings and closures per year, with no leaks, blockages, cracks, ruptures or flap escapes. - The artificial valve must not lead to thrombosis, so that patients do not need to take anticoagulants. - Operation (flap opening and closing, blood flow through the valve) must be as silent as possible, so as not to disturb the patient or those around him, day or night. The TRIFLO device is in clinical trial and is not approved for sale.
Request for quotes
Create one request and get multiple quotes form verified suppliers.
- Only relevant suppliers
- Data privacy compliant
- 100% free